Based on the profile of participants enrolled in retatrutide trials to date, the drug appears most relevant to adults living with obesity (BMI 30 kg/m) or those who are overweight (BMI 27 kg/m) with weight-related health conditions such as type 2 diabetes, hypertension, dyslipidaemia, or obstructive sleep apnoea
We have clinics in states including Tennessee, Kentucky, Indiana, Mississippi, Louisiana, Alabama, Arkansas, and North Carolina
If it is cloudy or contains particles, do not use it and contact your provider
The skin here is thinner, frequently exposed to the sun, and often washed, leading to slower responses
It targets two systems at once (GLP-1 and GIP) which means it can actually produce more weight loss than semaglutide for some people